Clinical phenotype and mortality in patients with idiopathic small bowel villous atrophy: a dual-centre international study.
Journal
European journal of gastroenterology & hepatology
ISSN: 1473-5687
Titre abrégé: Eur J Gastroenterol Hepatol
Pays: England
ID NLM: 9000874
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
pubmed:
14
4
2020
medline:
29
7
2021
entrez:
14
4
2020
Statut:
ppublish
Résumé
Causes of small-bowel villous atrophy (VA) include coeliac disease (CD), its complications and other rare non-coeliac enteropathies. However, forms of VA of unknown aetiology may also exist. We defined them as idiopathic VA (IVA). To retrospectively classify the largest cohort of IVA patients and compare their natural history with CD. Notes of 76 IVA patients attending two tertiary centres between January 2000 and March 2019 were retrospectively reviewed. CD, its complications and all the known causes of VA were excluded in all of them. Persistence of VA during follow-up and lymphoproliferative features were used to retrospectively classify IVA, as follows. Group 1: IVA with spontaneous histological recovery (50 patients). Group 2: persistent IVA without lymphoproliferative features (14 patients). Group 3: persistent IVA with lymphoproliferative features (12 patients). Survival was compared between IVA groups and 1114 coeliac patients. HLA was compared between IVA patients, coeliac patients and appropriate controls. Five-year survival was 96% in IVA group 1, 100% in IVA group 2, 27% in IVA group 3 and 97% in CD. On a multivariate analysis hypoalbuminemia (P = 0.002) and age at diagnosis (P = 0.04) predicted mortality in IVA. Group 2 showed association with HLA DQB1*0301 and DQB1*06. IVA consists of three groups of enteropathies with distinct clinical phenotypes and prognoses. Mortality in IVA is higher than in CD and mainly due to lymphoproliferative conditions necessitating more aggressive therapies.
Identifiants
pubmed: 32282540
doi: 10.1097/MEG.0000000000001726
pii: 00042737-202008000-00006
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
938-949Références
Lebwohl B, Sanders DS, Green PHR. Coeliac disease. Lancet. 2018; 391:70–81
Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA; American College of Gastroenterology. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013; 108:656–76; quiz 677
West J. Celiac disease and its complications: a time traveller’s perspective. Gastroenterology. 2009; 136:32–34
Biagi F, Marchese A, Ferretti F, Ciccocioppo R, Schiepatti A, Volta U, et al. A multicentre case control study on complicated coeliac disease: two different patterns of natural history, two different prognoses. BMC Gastroenterol. 2014; 14:139
Schiepatti A, Sanders DS, Zuffada M, Luinetti O, Iraqi A, Biagi F. Overview in the clinical management of patients with seronegative villous atrophy. Eur J Gastroenterol Hepatol. 2019; 31:409–417
DeGaetani M, Tennyson CA, Lebwohl B, Lewis SK, Abu Daya H, Arguelles-Grande C, et al. Villous atrophy and negative celiac serology: a diagnostic and therapeutic dilemma. Am J Gastroenterol. 2013; 108:647–653
Aziz I, Peerally MF, Barnes JH, Kandasamy V, Whiteley JC, Partridge D, et al. The clinical and phenotypical assessment of seronegative villous atrophy; a prospective UK centre experience evaluating 200 adult cases over a 15-year period (2000-2015). Gut. 2017; 66:1563–1572
Volta U, Caio G, Boschetti E, Giancola F, Rhoden KJ, Ruggeri E, et al. Seronegative celiac disease: shedding light on an obscure clinical entity. Dig Liver Dis. 2016; 48:1018–1022
Pallav K, Leffler DA, Tariq S, Kabbani T, Hansen J, Peer A, et al. Noncoeliac enteropathy: the differential diagnosis of villous atrophy in contemporary clinical practice. Aliment Pharmacol Ther. 2012; 35:380–390
Schiepatti A, Biagi F, Fraternale G, Vattiato C, Balduzzi D, Agazzi S, et al. Short article: mortality and differential diagnoses of villous atrophy without coeliac antibodies. Eur J Gastroenterol Hepatol. 2017; 29:572–576
Katz AJ, Grand RJ. All that flattens is not “sprue”. Gastroenterology. 1979; 76:375–377
Corazza GR, Biagi F, Volta U, Andreani ML, De Franceschi L, Gasbarrini G. Autoimmune enteropathy and villous atrophy in adults. Lancet. 1997; 350:106–109
Akram S, Murray JA, Pardi DS, Alexander GL, Schaffner JA, Russo PA, Abraham SC. Adult autoimmune enteropathy: Mayo Clinic Rochester experience. Clin Gastroenterol Hepatol. 2007; 5:1282–90; quiz 1245
Malamut G, Verkarre V, Suarez F, Viallard JF, Lascaux AS, Cosnes J, et al. The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease. Am J Gastroenterol. 2010; 105:2262–2275
Biagi F, Bianchi PI, Zilli A, Marchese A, Luinetti O, Lougaris V, et al. The significance of duodenal mucosal atrophy in patients with common variable immunodeficiency: a clinical and histopathologic study. Am J Clin Pathol. 2012; 138:185–189
Marthey L, Cadiot G, Seksik P, Pouderoux P, Lacroute J, Skinazi F, et al. Olmesartan-associated enteropathy: results of a national survey. Aliment Pharmacol Ther. 2014; 40:1103–1109
Ziegler TR, Fernández-Estívariz C, Gu LH, Fried MW, Leader LM. Severe villus atrophy and chronic malabsorption induced by azathioprine. Gastroenterology. 2003; 124:1950–1957
Boscá MM, Añón R, Mayordomo E, Villagrasa R, Balza N, Amorós C, et al. Methotrexate induced sprue-like syndrome. World J Gastroenterol. 2008; 14:7009–7011
Kamar N, Faure P, Dupuis E, Cointault O, Joseph-Hein K, Durand D, et al. Villous atrophy induced by mycophenolate mofetil in renal-transplant patients. Transpl Int. 2004; 17:463–467
Smale S, Tibble J, Sigthorsson G, Bjarnason I. Epidemiology and differential diagnosis of NSAID-induced injury to the mucosa of the small intestine. Best Pract Res Clin Gastroenterol. 2001; 15:723–738
Kaosombatwattana U, Limsrivilai J, Pongpaibul A, Maneerattanaporn M, Charatcharoenwitthaya P. Severe enteropathy with villous atrophy in prolonged mefenamic acid users - a currently under-recognized in previously well-recognized complication: case report and review of literature. Medicine (Baltimore). 2017; 96:e8445
Levinson JD, Nastro LJ. Giardiasis with total villous atrophy. Gastroenterology. 1978; 74:271–275
Kapembwa MS, Batman PA, Fleming SC, Griffin GE. HIV enteropathy. Lancet. 1989; 2:1521–1522
Madsen JE, Vetvik K, Aase S. Helicobacter-associated duodenitis and gastric metaplasia in duodenal ulcer patients. APMIS. 1991; 99:997–1000
Voutilainen M, Juhola M, Färkkilä M, Sipponen P. Gastric metaplasia and chronic inflammation at the duodenal bulb mucosa. Dig Liver Dis. 2003; 35:94–98
Fung WP, Tan KK, Yu SF, Sho KM. Malabsorption and subtotal villous atrophy secondary to pulmonary and intestinal tuberculosis. Gut. 1970; 11:212–216
Lappinga PJ, Abraham SC, Murray JA, Vetter EA, Patel R, Wu TT. Small intestinal bacterial overgrowth: histopathologic features and clinical correlates in an underrecognized entity. Arch Pathol Lab Med. 2010; 134:264–270
Foukas PG, de Leval L. Recent advances in intestinal lymphomas. Histopathology. 2015; 66:112–136
Culliford A, Markowitz D, Rotterdam H, Green PH. Scalloping of duodenal mucosa in Crohn's disease. Inflamm Bowel Dis. 2004; 10:270–273
Brown IS, Bettington A, Bettington M, Rosty C. Tropical sprue: revisiting an underrecognized disease. Am J Surg Pathol. 2014; 38:666–672
Rubio-Tapia A, Talley NJ, Gurudu SR, Wu TT, Murray JA. Gluten-free diet and steroid treatment are effective therapy for most patients with collagenous sprue. Clin Gastroenterol Hepatol. 2010; 8:344–349.e3
Pensieri MV, Pulvirenti F, Schiepatti A, Maimaris S, Lattanzio S, Quinti I, et al. The high mortality of patients with common variable immunodeficiency and small bowel villous atrophy. Scand J Gastroenterol. 2019; 54:164–168
Biagi F, Corazza GR. Defining gluten refractory enteropathy. Eur J Gastroenterol Hepatol. 2001; 13:561–565
Daum S, Weiss D, Hummel M, Ullrich R, Heise W, Stein H, et al.; Intestinal Lymphoma Study Group. Frequency of clonal intraepithelial T lymphocyte proliferations in enteropathy-type intestinal T cell lymphoma, coeliac disease, and refractory sprue. Gut. 2001; 49:804–812
Brown IS, Bettington A, Bettington M, Rosty C. Self-limited coeliac-like enteropathy: a series of 18 cases highlighting another coeliac disease mimic. Histopathology. 2016; 68:254–261
Goldstein NS. Non-gluten sensitivity-related small bowel villous flattening with increased intraepithelial lymphocytes: not all that flattens is celiac sprue. Am J Clin Pathol. 2004; 121:546–550
van Wanrooij RL, Müller DM, Neefjes-Borst EA, Meijer J, Koudstaal LG, Heideman DA, et al. Optimal strategies to identify aberrant intra-epithelial lymphocytes in refractory coeliac disease. J Clin Immunol. 2014; 34:828–835
Biagi F, Bianchi PI, Vattiato C, Marchese A, Trotta L, Badulli C, et al. Influence of HLA-DQ2 and DQ8 on severity in celiac disease. J Clin Gastroenterol. 2012; 46:46–50
Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol. 1999; 11:1185–1194
Olerup O, Zetterquist H. HLA-DRB1*01 subtyping by allele-specific PCR amplification: a sensitive, specific and rapid technique. Tissue Antigens. 1991; 37:197–204
Jordan F, McWhinnie AJ, Turner S, Gavira N, Calvert AA, Cleaver SA, et al. Comparison of HLA-DRB1 typing by DNA-RFLP, PCR-SSO and PCR-SSP methods and their application in providing matched unrelated donors for bone marrow transplantation. Tissue Antigens. 1995; 45:103–110
Masia R, Peyton S, Lauwers GY, Brown I. Gastrointestinal biopsy findings of autoimmune enteropathy: a review of 25 cases. Am J Surg Pathol. 2014; 38:1319–1329
Megiorni F, Pizzuti A. HLA-DQA1 and HLA-DQB1 in celiac disease predisposition: practical implications of the HLA molecular typing. J Biomed Sci. 2012; 19:88
Lin J, McKenna BJ, Appelman HD. Morphologic findings in upper gastrointestinal biopsies of patients with ulcerative colitis: a controlled study. Am J Surg Pathol. 2010; 34:1672–1677
Liu H, Brais R, Lavergne-Slove A, Jeng Q, Payne K, Ye H, et al. Continual monitoring of intraepithelial lymphocyte immunophenotype and clonality is more important than snapshot analysis in the surveillance of refractory coeliac disease. Gut. 2010; 59:452–460
Hussein S, Gindin T, Lagana SM, Arguelles-Grande C, Krishnareddy S, Alobeid B, et al. Clonal T cell receptor gene rearrangements in coeliac disease: implications for diagnosing refractory coeliac disease. J Clin Pathol. 2018; 71:825–831
Celli R, Hui P, Triscott H, Bogardus S, Gibson J, Hwang M, Robert ME. Clinical insignficance of monoclonal T-cell populations and duodenal intraepithelial T-cell phenotypes in celiac and nonceliac patients. Am J Surg Pathol. 2019; 43:151–160
Louie CY, DiMaio MA, Matsukuma KE, Coutre SE, Berry GJ, Longacre TA. Idelalisib-associated enterocolitis: clinicopathologic features and distinction from other enterocolitides. Am J Surg Pathol. 2015; 39:1653–1660
Ciccocioppo R, Corazza GR. Mesenchymal stromal cells: an opportunity to treat chronic inflammatory intestinal conditions. Cytotherapy. 2018; 20:1223–1226
Ahmed Z, Imdad A, Connelly JA, Acra S. Autoimmune enteropathy: an updated review with special focus on stem cell transplant therapy. Dig Dis Sci. 2019; 64:643–654
Duarte RF, Labopin M, Bader P, Basak GW, Bonini C, Chabannon C, et al.; European Society for Blood and Marrow Transplantation (EBMT). Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019. Bone Marrow Transplant. 2019; 54:1525–1552